Focus on: Associated Partners
Focus on IMI's Associated Partners mechanism.
Site Search
Site Search
Displaying results 91 - 100 of 893
PROMISE
Preparing for RSV immunisation and surveillance in Europe
PRISM 2
Psychiatric ratings using intermediate stratified markers 2
REsolution
Add medical genetic solutions to RESOLUTE (REsolution)
INNODIA diabetes findings prompt new research into other autoimmune diseases
Most research into autoimmune diseases focuses on the role of the immune system. But INNODIA research underscores the importance of studying the tissues under attack as well.
“Collaborative efforts are invaluable for advancing autism science”
The Simons Foundation has partnered with IMI in two autism research projects through the Associated Partner mechanism. Paul Wang, SFARI’s Deputy Director of Clinical Research, spoke to the IMI programme office about the benefits of the collaboration.
Rapid evolution and host immunity drive antibiotic resistance in acute infection
COMBACTE-MAGNET have added to our understanding of how resistance emerges during infection
“The IMI model aligns with our way of working”
TB Alliance is one of IMI's Associated Partners. Ana Maria Harkins, its Director of External Affairs, says that the partnership with IMI allows them to expand funding beyond a small and mostly static group of donors
Got a promising potential antibiotic? Our GNA NOW project wants to hear from you!
IMI’s GNA NOW project is looking for a novel antibiotic programme to progress to Investigational New Drug (IND). The deadline for expressions of interest is 18 June.
